PURPOSE: Human daily total water intake (TWI) has a large inter-individual range. Recently, water supplementation has been suggested as a potential preventative and therapeutic modality. Thus, we aimed to measure hydration biomarkers in women with high (HIGH) versus low (LOW) daily TWI to determine baseline differences, and the efficacy of these markers during a systematic alteration in TWI. METHODS: This cohort study identified 14 HIGH [3.34 (0.56) L day(-1)] and 14 LOW [1.62 (0.48) L day(-1)] from 120 women. Next, fluid intake was decreased in HIGH [2.00 (0.21) L day(-1)] while LOW increased [3.50 (0.13) L day(-1)] across 4 days. Body mass, fluid intake, serum osmolality (S osmo), total plasma protein (TPP), 24 h urine osmolality, and 24 h urine volume, were measured on each day of modified TWI. Estimated plasma volume (E pv) was calculated using measured body mass and hematocrit values. RESULTS: At baseline, urinary markers and TPP differentiated HIGH from LOW [7.0 (0.3) versus 7.3 (0.3) mg dL(-1), respectively]. Upon TWI intervention, (1) body mass decreased in HIGH [-0.7 (1.1) kg, p = 0.010)] but did not increase in LOW [+0.0 (0.6) kg, p = 0.110], (2) E pv decreased 2.1 (2.4) %, p = 0.004, (3) urine osmolality increased in HIGH [397 (144)-605 (230) mOsm kg(-1), p < 0.001] and decreased in LOW [726 (248)-265 (97) mOsm kg(-1) p < 0.001], and (4) no changes of serum osmolality occurred in either HIGH or LOW (all p > 0.05). CONCLUSIONS: Urinary markers and TPP are sensitive measures to habitual high and low TWI and to changes in TWI. Both groups through urinary and some hematological responses following TWI manipulation achieved regulation of hemoconcentration.
PURPOSE:Human daily total water intake (TWI) has a large inter-individual range. Recently, water supplementation has been suggested as a potential preventative and therapeutic modality. Thus, we aimed to measure hydration biomarkers in women with high (HIGH) versus low (LOW) daily TWI to determine baseline differences, and the efficacy of these markers during a systematic alteration in TWI. METHODS: This cohort study identified 14 HIGH [3.34 (0.56) L day(-1)] and 14 LOW [1.62 (0.48) L day(-1)] from 120 women. Next, fluid intake was decreased in HIGH [2.00 (0.21) L day(-1)] while LOW increased [3.50 (0.13) L day(-1)] across 4 days. Body mass, fluid intake, serum osmolality (S osmo), total plasma protein (TPP), 24 h urine osmolality, and 24 h urine volume, were measured on each day of modified TWI. Estimated plasma volume (E pv) was calculated using measured body mass and hematocrit values. RESULTS: At baseline, urinary markers and TPP differentiated HIGH from LOW [7.0 (0.3) versus 7.3 (0.3) mg dL(-1), respectively]. Upon TWI intervention, (1) body mass decreased in HIGH [-0.7 (1.1) kg, p = 0.010)] but did not increase in LOW [+0.0 (0.6) kg, p = 0.110], (2) E pv decreased 2.1 (2.4) %, p = 0.004, (3) urine osmolality increased in HIGH [397 (144)-605 (230) mOsm kg(-1), p < 0.001] and decreased in LOW [726 (248)-265 (97) mOsm kg(-1) p < 0.001], and (4) no changes of serum osmolality occurred in either HIGH or LOW (all p > 0.05). CONCLUSIONS: Urinary markers and TPP are sensitive measures to habitual high and low TWI and to changes in TWI. Both groups through urinary and some hematological responses following TWI manipulation achieved regulation of hemoconcentration.
Authors: Lawrence E Armstrong; Amy C Pumerantz; Kelly A Fiala; Melissa W Roti; Stavros A Kavouras; Douglas J Casa; Carl M Maresh Journal: Int J Sport Nutr Exerc Metab Date: 2010-04 Impact factor: 4.599
Authors: M J McKinley; M J Cairns; D A Denton; G Egan; M L Mathai; A Uschakov; J D Wade; R S Weisinger; B J Oldfield Journal: Physiol Behav Date: 2004-07
Authors: Erica T Perrier; Lawrence E Armstrong; Michel Daudon; Stavros Kavouras; Max Lafontan; Florian Lang; François Péronnet; Jodi D Stookey; Ivan Tack; Alexis Klein Journal: Obes Facts Date: 2014-04-04 Impact factor: 3.942
Authors: Adam D Seal; Abigail T Colburn; Evan C Johnson; François Péronnet; Lisa T Jansen; J D Adams; Costas N Bardis; Isabelle Guelinckx; Erica T Perrier; Stavros A Kavouras Journal: Eur J Nutr Date: 2022-08-09 Impact factor: 4.865
Authors: Evan C Johnson; Colleen X Muñoz; Liliana Jimenez; Laurent Le Bellego; Brian R Kupchak; William J Kraemer; Douglas J Casa; Carl M Maresh; Lawrence E Armstrong Journal: Nutrients Date: 2016-05-18 Impact factor: 5.717
Authors: Lee Hooper; Asmaa Abdelhamid; Adam Ali; Diane K Bunn; Amy Jennings; W Garry John; Susan Kerry; Gregor Lindner; Carmen A Pfortmueller; Fredrik Sjöstrand; Neil P Walsh; Susan J Fairweather-Tait; John F Potter; Paul R Hunter; Lee Shepstone Journal: BMJ Open Date: 2015-10-21 Impact factor: 2.692
Authors: Amy L McKenzie; Colleen X Muñoz; Lindsay A Ellis; Erica T Perrier; Isabelle Guelinckx; Alexis Klein; Stavros A Kavouras; Lawrence E Armstrong Journal: Eur J Nutr Date: 2015-11-16 Impact factor: 5.614
Authors: Amy L McKenzie; Erica T Perrier; Isabelle Guelinckx; Stavros A Kavouras; Giselle Aerni; Elaine C Lee; Jeff S Volek; Carl M Maresh; Lawrence E Armstrong Journal: Eur J Nutr Date: 2016-08-12 Impact factor: 5.614